Minim Invasive Neurosurg 2011; 54(05/06): 290
DOI: 10.1055/s-0031-1297988
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Letter to the Editor: Percutaneous Chemical Dorsal ­Sympathectomy for Hyperhidrosis

A.E. P. Cameron1, C. Connery2, J.R. M. De Campos3, M. Hashmonai4, P. B. Licht5, C. H. Schick6, G. Bischof7, on behalf of the International Society of Symapathetic Surgery
  • 1Department of Surgery, The Ipswich ­Hospital, Ipswich, UK
  • 2Department of Surgery, St Luke’s-­Roosevelt Hospital Center, New York, NY, USA
  • 3Department of Thoracic Surgery, University of Sao Paolo, Sao Paolo, Brazil
  • 4Faculty of Medicine, Technion-Israel Institue of Technology, Haifa, Israel
  • 5Department of Cardiothoracic Surgery, Odense University ­Hospital, Odense, Denmark
  • 6German Hyperhidrosiscenter, Surgery Isar Clinic, Munich, Germany
  • 7Department of Surgery, St Josef ­Hospital, Surgery, Vienna, Austria
Further Information

Publication History

Publication Date:
25 January 2012 (online)

Sir,

We read with interest the article of Dr. Ebrahim [1]. The use of sympathetic block to treat palmar hyperhidrosis was tested in the past. 2 series were published [2] [3]. The group of Adler noticed a 10% recurrence at 4 months. A subsequent follow-up of their cases [4] revealed 40% recurrences and the method of treating palmar hyperhidrosis by phenol blocks was abandoned by this group of authors. In another study of chemical lumbar blocks performed to treat plantar hyperhidrosis [5], recurrence occurred in 89.9% of patients at 6–18 months. Taking into consideration these medium-term results, we wonder at the overall merits of chemical blocks over surgery for the treatment of primary hyperhidrosis. Dr. Ebrahim has a 1-year follow-up of his patients and already noticed 10% recurrences. We urge him to follow his patients for another year and publish at that time his results.